HuGE Literature Finder
Records
1
-
20
| Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
| Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis. International journal of cancer 2021 Feb . Hata Atsushi, Nakajima Takahiro, Matsusaka Keisuke, Fukuyo Masaki, Nakayama Manabu, Morimoto Junichi, Ito Yuki, Yamamoto Takayoshi, Sakairi Yuichi, Rahmutulla Bahityar, Ota Satoshi, Wada Hironobu, Suzuki Hidemi, Iwata Takekazu, Matsubara Hisahiro, Ohara Osamu, Yoshino Ichiro, Kaneda Atsus |
| KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials. Frontiers in oncology 2021 11 659200. Zhu Hongyuan, Xie Daipeng, Yu Yunfang, Yao Lintong, Xu Bin, Huang Luyu, Wu Shaowei, Li Fasheng, Zheng Yating, Liu Xinyi, Xie Wenzhuan, Huang Mengli, Li Hao, Zheng Shaopeng, Zhang Dongkun, Qiao Guibin, Chan Lawrence W C, Zhou Hai |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition. Cancer discovery 2020 Oct . Binkley Michael S, Jeon Young-Jun, Nesselbush Monica, Moding Everett J, Nabet Barzin Y, Almanza Diego, Kunder Christian, Stehr Henning, Yoo Christopher H, Rhee Siyeon, Xiang Michael, Chabon Jacob J, Hamilton Emily, Kurtz David M, Gojenola Linda, Owen Susie Grant, Ko Ryan B, Shin June Ho, Maxim Peter G, Lui Natalie Shaubie, Backhus Leah M, Berry Mark F, Shrager Joseph B, Ramchandran Kavitha J, Padda Sukhmani K, Das Millie, Neal Joel W, Wakelee Heather A, Alizadeh Ash A, Loo Billy W, Diehn Maximili |
| Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical lung cancer 2020 Oct . Riess Jonathan W, Frankel Paul, Shackelford David, Dunphy Mark, Badawi Ramsey D, Nardo Lorenzo, Cherry Simon R, Lanza Ian, Reid Joel, Gonsalves Wilson I, Kunos Charles, Gandara David R, Lara Primo N, Newman Edward, Paik Paul |
| Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
| Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer. Aging 2020 Jul 12 . Zhang Manman, Zhang Lele, Li Yan, Sun Feng, Fang Ya, Zhang Ruijia, Wu Jin, Zhou Guanbiao, Song Huaidong, Xue Liqiong, Han Bing, Zheng Cuix |
| Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients. Scientific reports 2020 Feb 10 (1): 2070. Jiang Ruirui, Zhang Bo, Teng Xiaodong, Hu Peizhen, Xu Sanpeng, Zheng Zuyu, Liu Rui, Tang Tingdong, Ye Fe |
| Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2019 Aug 134 42-45. Hellyer Jessica A, Stehr Henning, Das Millie, Padda Sukhmani K, Ramchandran Kavitha, Neal Joel W, Diehn Maximilian, Wakelee Heather |
| Precision oncology of lung cancer: genetic and genomic differences in Chinese population. NPJ precision oncology 2019 3 14. Shen Hongbing, Zhu Meng, Wang Che |
| Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct . Arbour Kathryn C, Jordan Emmet J, Kim Hyunjae Ryan, Dienstag Jordan, Yu Helena, Sanchez-Vega Francisco, Lito Piro, Berger Michael F, Solit David B, Hellmann Matthew D, Kris Mark G, Rudin Charles M, Ni Andy, Arcila Maria E, Ladanyi Marc, Riely Gregory |
| PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations. Oncoimmunology 2016 May 5 (5): e1131379. Scheel Andreas H, Ansén Sascha, Schultheis Anne M, Scheffler Matthias, Fischer Rieke N, Michels Sebastian, Hellmich Martin, George Julie, Zander Thomas, Brockmann Michael, Stoelben Erich, Groen Harry, Timens Wim, Perner Sven, von Bergwelt-Baildon Michael, Büttner Reinhard, Wolf Jürg |
| Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 07 34 (19): 2247-57. Kawaguchi Tomoya, Koh Yasuhiro, Ando Masahiko, Ito Norimasa, Takeo Sadanori, Adachi Hirofumi, Tagawa Tsutomu, Kakegawa Seiichi, Yamashita Motohiro, Kataoka Kazuhiko, Ichinose Yukito, Takeuchi Yukiyasu, Serizawa Masakuni, Tamiya Akihiro, Shimizu Shigeki, Yoshimoto Naoki, Kubo Akihito, Isa Shun-Ichi, Saka Hideo, Matsumura Akihi |
| Keap1 mutations in lung cancer patients. Oncology letters 2013 Sep 6 (3): 719-721. Sasaki Hidefumi, Suzuki Ayumi, Shitara Masayuki, Okuda Katsuhiro, Hikosaka Yu, Moriyama Satoru, Yano Motoki, Fujii Yoshita |
| Genotype analysis of the NRF2 gene mutation in lung cancer. International journal of molecular medicine 2013 May 31 (5): 1135-8. Sasaki Hidefumi, Suzuki Ayumi, Shitara Masayuki, Hikosaka Yu, Okuda Katsuhiro, Moriyama Satoru, Yano Motoki, Fujii Yoshita |
| Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012 Sep 489 (7417): 519-25. Authors are not available |
| Increased NRF2 gene (NFE2L2) copy number correlates with mutations in lung squamous cell carcinomas. Molecular medicine reports 2012 Aug 6 (2): 391-4. Sasaki Hidefumi, Shitara Masayuki, Yokota Keisuke, Hikosaka Yu, Moriyama Satoru, Yano Motoki, Fujii Yoshita |
| Mutation of the Nrf2 gene in non-small cell lung cancer. Molecular biology reports 2012 Apr 39 (4): 4743-7. Hu Yi, Ju Yanfang, Lin Dongmei, Wang Zhikuan, Huang Yurong, Zhang Sujie, Wu Chao, Jiao Shuncha |
| NFE2L2 gene mutation in male Japanese squamous cell carcinoma of the lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Jun 5 (6): 786-9. Sasaki Hidefumi, Hikosaka Yu, Okuda Katsuhiro, Kawano Osamu, Moriyama Satoru, Yano Motoki, Fujii Yoshita |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 18, 2022
- Content source: